Note 8 - Shareholders' Equity

9 Months Ended

Nov. 30, 2014

Notes to Financial Statements

Stockholders' Equity Note Disclosure [Text Block]

8 . SHAREHOLDERS’ EQUITY

During the 39 weeks ended November 30, 2014, the Company issued 75 shares pursuant to the exercises of stock options and received proceeds from such exercises, recognized stock-based compensation expense and recognized tax benefits from stock-based compensation of $1,602, $912 and $38, respectively. These transactions resulted in a $2,552 increase in additional paid-in capital during the period.

The Company announced on October 18, 2012 that its Board of Directors had authorized the Company’s purchase, on the open market and in privately negotiated transactions, of up to 1,000 shares of its common stock.

Between October 18, 2012 and November 25, 2012, the Company purchased 4 shares pursuant to such authorization at an aggregate purchase price of $93; and during the 13 weeks ended November 30, 2014, the Company purchased an additional 8 shares pursuant to such authorization at an aggregate purchase price of $172.

The Company announced on January 8, 2015 that its Board of Directors has authorized the Company’s purchase, on the open market and in privately negotiated transactions, of up to 1,250 shares of its common stock, representing approximately 6% of the Company’s 20,946 total outstanding shares as of the close of business on January 7, 2015. This authorization supersedes all prior Board of Directors’ authorizations to purchase shares of the Company’s common stock.